Skip navigation

Chemical Ascorbic Acid

1–50 of 764 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 6-O-palmitol-ascorbate-2-O-phosphate response to mechanical stimulus 6-O-palmitol-ascorbate-2-O-phosphate results in decreased response to mechanical stimulus 1: Mus musculus Cartilage, Articular | Chondrocytes   1
2. 6-O-palmitol-ascorbate-2-O-phosphate positive regulation of superoxide anion generation response to mechanical stimulus [6-O-palmitol-ascorbate-2-O-phosphate results in decreased response to mechanical stimulus] which results in decreased positive regulation of superoxide anion generation 1: Mus musculus Cartilage, Articular | Chondrocytes   1
3. 6-O-palmitol-ascorbate-2-O-phosphate response to mechanical stimulus positive regulation of superoxide anion generation [6-O-palmitol-ascorbate-2-O-phosphate results in decreased response to mechanical stimulus] which results in decreased positive regulation of superoxide anion generation 1: Mus musculus Cartilage, Articular | Chondrocytes   1
4. ascorbate-2-phosphate membrane lipid catabolic process ascorbate-2-phosphate results in decreased membrane lipid catabolic process 1: Rattus norvegicus Liver | Hepatocytes | Cell Line, Tumor   1
5. Ascorbic Acid apoptotic process Ascorbic Acid results in decreased apoptotic process 1: Homo sapiens HL-60 Cells
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
6. Ascorbic Acid membrane lipid catabolic process Ferrous Compounds [Ferrous Compounds co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process     1
7. Ascorbic Acid membrane lipid catabolic process Ferrous Compounds | Propofol Propofol inhibits the reaction [[Ascorbic Acid co-treated with Ferrous Compounds] results in increased membrane lipid catabolic process]     1
8. Ascorbic Acid membrane lipid catabolic process Ferrous Compounds | Vitamin E Vitamin E inhibits the reaction [[Ascorbic Acid co-treated with Ferrous Compounds] results in increased membrane lipid catabolic process]     1
9. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 2: Mus musculus | Rattus norvegicus Brain   2
10. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Liver   1
11. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Kidney   1
12. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Lung   1
13. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Heart   1
14. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Aorta   1
15. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Brain   1
16. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Liver   1
17. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Kidney   1
18. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Lung   1
19. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Heart   1
20. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Aorta   1
21. Ascorbic Acid apoptotic process AGT Ascorbic Acid inhibits the reaction [AGT protein modified form results in increased apoptotic process] 1: Mus musculus Cell Line, Transformed | Mesangial Cells
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
22. Ascorbic Acid apoptotic process Ascorbic Acid results in increased apoptotic process 1: Homo sapiens Colon | Tumor Cells, Cultured
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
23. Ascorbic Acid apoptotic process Adenosine Triphosphate | Vitamin E [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Adenosine Triphosphate results in increased apoptotic process] 1: Rattus norvegicus Adrenal Glands | PC12 Cells
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
24. Ascorbic Acid cell death 2,3,2-tetramine [2,3,2-tetramine co-treated with Ascorbic Acid] results in increased cell death 1: Homo sapiens Blood Cells | HL-60 Cells
8 genes: CDKN1B | CTSD | EMP1 | EMP3 | HMOX1 | OLR1 | PMP22 | TGFB2
1
25. Ascorbic Acid membrane lipid catabolic process potassium bromate Ascorbic Acid inhibits the reaction [potassium bromate results in increased membrane lipid catabolic process] 1: Rattus norvegicus Kidney   1
26. Ascorbic Acid regulation of organ growth potassium bromate Ascorbic Acid inhibits the reaction [potassium bromate results in increased regulation of organ growth] 1: Rattus norvegicus Kidney 1 gene: SOD1 1
27. Ascorbic Acid membrane lipid catabolic process ferric ammonium citrate Ascorbic Acid affects the reaction [ferric ammonium citrate results in increased membrane lipid catabolic process] 1: Rattus norvegicus Myocardium | Cells, Cultured   1
28. Ascorbic Acid DNA catabolic process Bleomycin Ascorbic Acid promotes the reaction [Bleomycin results in increased DNA catabolic process]   1 gene: DNASE1 1
29. Ascorbic Acid membrane lipid catabolic process CAT CAT inhibits the reaction [Ascorbic Acid results in increased membrane lipid catabolic process] 1: Rattus norvegicus Epidermis | Microsomes   1
30. Ascorbic Acid membrane lipid catabolic process adenosine diphosphate-ferric chelate [Ascorbic Acid co-treated with adenosine diphosphate-ferric chelate] results in increased membrane lipid catabolic process 1: Rattus norvegicus Epidermis | Microsomes   1
31. Ascorbic Acid membrane lipid catabolic process Ascorbic Acid results in increased membrane lipid catabolic process 1: Rattus norvegicus Epidermis | Microsomes   1
32. Ascorbic Acid membrane lipid catabolic process Ascorbic Acid results in decreased membrane lipid catabolic process 1: Rattus norvegicus Microsomes, Liver   1
33. Ascorbic Acid membrane lipid catabolic process Vitamin E [Vitamin E co-treated with Ascorbic Acid] results in decreased membrane lipid catabolic process 1: Rattus norvegicus Microsomes, Liver   1
34. Ascorbic Acid membrane lipid catabolic process alpha-Linolenic Acid | Paraquat Ascorbic Acid promotes the reaction [alpha-Linolenic Acid promotes the reaction [Paraquat results in increased membrane lipid catabolic process]] 1: Rattus norvegicus Hepatocytes | Cells, Cultured   1
35. Ascorbic Acid membrane lipid catabolic process alpha-Linolenic Acid | ferrous sulfate Ascorbic Acid promotes the reaction [[alpha-Linolenic Acid co-treated with ferrous sulfate] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Hepatocytes | Cells, Cultured   1
36. Ascorbic Acid membrane lipid catabolic process Ascorbic Acid results in increased membrane lipid catabolic process 1: Rattus norvegicus Kidney   1
37. Ascorbic Acid membrane lipid catabolic process alpha-Tocopherol alpha-Tocopherol inhibits the reaction [Ascorbic Acid results in increased membrane lipid catabolic process] 1: Rattus norvegicus Kidney   1
38. Ascorbic Acid membrane lipid catabolic process ferrous chloride | Hydrogen Peroxide [Hydrogen Peroxide co-treated with ferrous chloride co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Prosencephalon | Synapses | Cell Membrane   1
39. Ascorbic Acid membrane lipid catabolic process 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | ferrous chloride | Hydrogen Peroxide 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [[Hydrogen Peroxide co-treated with ferrous chloride co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Prosencephalon | Synapses | Cell Membrane   1
40. Ascorbic Acid membrane lipid catabolic process Ascorbic Acid results in decreased membrane lipid catabolic process 1: Homo sapiens Urine   1
41. Ascorbic Acid membrane lipid catabolic process Ascorbic Acid results in decreased membrane lipid catabolic process 1: Homo sapiens Serum   1
42. Ascorbic Acid response to oxidative stress Ferrous Compounds [Ferrous Compounds co-treated with Ascorbic Acid] results in increased response to oxidative stress 1: Mus musculus Blood Cells | Lymphocytes | Cell Line, Tumor
43 genes: ABCC1 | ABCC2 | AKT1 | APOE | APP | BCL2 | BCL2L1 | CAT | CYCS | DDIT3 | EGFR | EPAS1 | ERCC2 | G6PD | GCLC | GPX1 | GPX2 | GPX4 | GSR | HMOX1 | MMP2 | MPO | MT3 | NFKB1 | NQO1 | PCNA | PEBP1 | PON2 | PRDX1 | PRDX3 | PTGS1 | PTGS2 | RCAN1 | SLC23A2 | SLC7A11 | SOD1 | SOD2 | SOD3 | TLR4 | TP53 | TRP53 | TXN2 | TXNIP
1
43. Ascorbic Acid membrane lipid catabolic process edelfosine | Ferrous Compounds | Vitamin E [Vitamin E co-treated with edelfosine] inhibits the reaction [[Ferrous Compounds co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Mus musculus Blood Cells | Lymphocytes | Cell Line, Tumor   1
44. Ascorbic Acid membrane lipid catabolic process Ferrous Compounds | Vitamin E Vitamin E affects the reaction [[Ferrous Compounds co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Mus musculus Blood Cells | Lymphocytes | Cell Line, Tumor   1
45. Ascorbic Acid membrane lipid catabolic process Ferrous Compounds [Ferrous Compounds co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Mus musculus Blood Cells | Lymphocytes | Cell Line, Tumor   1
46. Ascorbic Acid cell death Dexamethasone Ascorbic Acid inhibits the reaction [Dexamethasone results in increased cell death] 1: Rattus norvegicus Muscle, Skeletal | Cells, Cultured
8 genes: CDKN1B | CTSD | EMP1 | EMP3 | HMOX1 | OLR1 | PMP22 | TGFB2
1
47. Ascorbic Acid apoptotic process Ascorbic Acid results in decreased apoptotic process  
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
48. Ascorbic Acid response to oxidative stress Amiodarone Ascorbic Acid inhibits the reaction [Amiodarone results in increased response to oxidative stress] 1: Mus musculus Hepatocytes | Cells, Cultured
43 genes: ABCC1 | ABCC2 | AKT1 | APOE | APP | BCL2 | BCL2L1 | CAT | CYCS | DDIT3 | EGFR | EPAS1 | ERCC2 | G6PD | GCLC | GPX1 | GPX2 | GPX4 | GSR | HMOX1 | MMP2 | MPO | MT3 | NFKB1 | NQO1 | PCNA | PEBP1 | PON2 | PRDX1 | PRDX3 | PTGS1 | PTGS2 | RCAN1 | SLC23A2 | SLC7A11 | SOD1 | SOD2 | SOD3 | TLR4 | TP53 | TRP53 | TXN2 | TXNIP
1
49. Ascorbic Acid membrane lipid catabolic process Vitamin E [Ascorbic Acid co-treated with Vitamin E] results in decreased membrane lipid catabolic process 1: Homo sapiens     1
50. Ascorbic Acid response to oxidative stress Ascorbic Acid results in decreased response to oxidative stress 1: Mus musculus Blastocyst
43 genes: ABCC1 | ABCC2 | AKT1 | APOE | APP | BCL2 | BCL2L1 | CAT | CYCS | DDIT3 | EGFR | EPAS1 | ERCC2 | G6PD | GCLC | GPX1 | GPX2 | GPX4 | GSR | HMOX1 | MMP2 | MPO | MT3 | NFKB1 | NQO1 | PCNA | PEBP1 | PON2 | PRDX1 | PRDX3 | PTGS1 | PTGS2 | RCAN1 | SLC23A2 | SLC7A11 | SOD1 | SOD2 | SOD3 | TLR4 | TP53 | TRP53 | TXN2 | TXNIP
1
1–50 of 764 results.